Cadila Healthcare reports 40% rise in Q2 consolidated net profit

23 Oct 2015 Evaluate

Cadila Healthcare has reported results for second quarter ended September 30, 2015.

The company has reported 67.96% rise in its net profit at Rs 614.08 crore for the quarter ended September 30, 2015 as compared to Rs 365.61 crore for the same quarter in the previous year. The company’s total income has increased by 41.52% to Rs 1976.45 crore for the quarter under review from Rs 1396.60 crore for the corresponding quarter of the previous year.

On the consolidated basis, the company has reported 40.57% rise in its net profit/(loss) after taxes, minority interest and share in profit/(loss) of associates at Rs 390.91 crore for the quarter ended September 30, 2015 as compared to Rs 278.09 crore for the same quarter in the previous year. Total income of the company has increased by 16.99% at Rs 2483.19 crore for quarter under review as compared to Rs 2122.61 crore for the quarter ended September 30, 2014.   

Zydus Lifesciences Share Price

924.35 -7.10 (-0.76%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×